Parmax Pharma Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/26/2026

Company Profile

IndustryDrug Manufacturers - Specialty & Generic

SectorHealthcare

ExchangeBSE

Market Capitalization510.31 mln

Piotroski F-Score

1 / 9

Very weak

Beneish M-Score

0.24

Highly suspicious

Relative Strength

88 / 100

Strongly outperforming

Pre-Tax Margin

-16%

Loss-making

ROE

21.77

Strong

Altman Z-Score

1.82

Borderline

Business Description

Founded in 1994 and headquartered in Rajkot, India, Parmax Pharma Limited produces and distributes active pharmaceutical ingredients, drug intermediates, and specialty chemicals. The company has built its presence within India's pharmaceutical industry over three decades of operation.

Key Fundamentals

EPS-3.20

ROE21.77

RPS49.16

ROIC-11.11

ROA-5.56

Interest Cover-3.03

EBITDA, mln-3.90

EV / EBITDA-268

EV / EBIT-63.57

Revenue, mln184

EV / Revenue5.67

Quote Details

Last 135.05

Change -1.35 (-0.99%)

Open 135.05

Volume 657

Turnover 88,728

Average Volume 6,175.86

Financial Ratios

Pre-Tax Profit Margin-16

Current Ratio0.74

Price / Sales2.78

Financial Strength

Altman Z-Score1.82

Piotroski F-Score 1 / 9

Beneish M-Score0.24

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-0.99%	80 / 100
1 Month	28.99%	98 / 100
2 Months	246%	100 / 100
6 Months	347%	100 / 100
1 Year	267%	99 / 100